Human Intervention Study to Increase 25-hydroxyvitamin D Levels (WeKo)

February 18, 2023 updated by: Christine Dawczynski,PhD, University of Jena

Human Intervention Study to Increase 25-hydroxyvitamin D Levels by Regular Consumption of Wheat Germ Oil (UV-treated) vs. Wheat Germ Oil Untreated (Control)

The interventional study will evaluate effectiveness and potential of a regularly consumption of wheat germ oil (UV treated) vs. wheat germ oil (UV untreated) to increase plasma vitamin D levels ín humans.

Study Overview

Detailed Description

The interventional study in parallel design will evaluate the effectiveness and potential of a daily consumption of wheat germ oil (UV treated vs. untreated) to increase plasma vitamin D levels in humans.

Wheat germ oil is naturally rich in vitamin D precursors (ergosterol and 7-dehydrocholesterol), which are converted into vitamin D2 and vitamin D3 by a defined UV light irradiation for the present study.

Half of the participants will consume UV-treated wheat germ oil (intervention) and the other part will consume traditional wheat germ oil (untreated, control). The subjects will consume 10 ml of wheat germ oil per day over an entire period of 6 weeks (no follow-up).

On the basis of the planned human intervention study (randomized, single-blind, parallel design) it will be investigated to what extent a regular consumption of wheat germ oil (UV-treated) can contribute to the increase of plasma 25 (OH) D levels.

The comparison is made against the intake of traditional (untreated) wheat germ oil (control).

The study fits with the strategy of the Competence Cluster for Nutrition and Cardiovascular Health (nutriCARD), Halle-Jena-Leipzig, Germany (www.nutriCARD.de) and the study collaborators are active members of the nutriCARD cluster.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Thuringia
      • Jena, Thuringia, Germany, 07743
        • Friedrich-Schiller-University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • healthy subjects
  • plasma 25(OH) vitamin D < 50 nmol/l
  • nutritional habits: western diet

Exclusion Criteria:

  • intake of lipid-lowering medications
  • gastrointestinal diseases, diabetes mellitus type I and II
  • intake of supplements (vitamin D supplements, fish oil capsules, vitamins and minerals) 3 months before and during the study
  • relevant food allergies / intolerances
  • visit to the solarium (within 4 weeks before beginning of the study and during the study)
  • stay in the mountains / skiing (within 4 weeks before beginning of studies and during the study)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Wheat germ oil (UV treated)

Wheat germ oil is naturally rich in vitamin D precursors (ergosterol and 7-dehydrocholesterol), which are converted into vitamin D2 and vitamin D3 by a defined UV light irradiation for the present study (wheat germ oil (UV treated).

The wheat germ oil (UV treated) is dispensed in dark glass bottles without label. The distinction between the groups is based on the expiration date (08.05.2018 vs. 09.05.2018). The distinction between the groups is not possible for the participants.

The daily dosage of wheat germ oil is 10 ml and the study products will be consumed over an entire period of 6 weeks (no follow-up).

Recommendation for intake: pure before a main meal.

Placebo Comparator: Wheat germ oil (untreated)

commercial available wheat germ oil The wheat germ oil (untreated) is dispensed in dark glass bottles without label. The distinction between the groups is based on the expiration date (08.05.2018 vs. 09.05.2018). The distinction between the groups is not possible for the participants.

The daily dosage of wheat germ oil is 10 ml and the study products will be consumed over an entire period of 6 weeks (no follow-up).

Recommendation for intake: pure before a main meal.

No Intervention: Control
no study products

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vitamin D status
Time Frame: change from baseline after 3 and 6 weeks
plasma levels of 25OHD2, 25OHD3 (nmol/l)
change from baseline after 3 and 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood lipids
Time Frame: change from baseline after 3 and 6 weeks
total cholesterol, LDL cholesterol, HDL cholesterol, triacylglycerides (mmol/L)
change from baseline after 3 and 6 weeks
Blood glucose
Time Frame: change from baseline after 3 and 6 weeks
fasting blood glucose (mmol/l)
change from baseline after 3 and 6 weeks
Insulin
Time Frame: change from baseline after 3 and 6 weeks
insulin (units/ml)
change from baseline after 3 and 6 weeks
soluble Klotho (sKlotho)
Time Frame: change from baseline after 3 and 6 weeks
sKlotho is a component of the FGF23 system and is associated with longevity
change from baseline after 3 and 6 weeks
Fibroblast growth factor 23 (FGF23)
Time Frame: change from baseline after 3 and 6 weeks
FGF23 is a regulator of vitamin D metabolism and also a risk factor for heart failure
change from baseline after 3 and 6 weeks
Fatty acid distribution (erythrocytes)
Time Frame: change from baseline after 3 and 6 weeks
fatty acid distribution in erythrocyte lipids (% fatty acid methyl ester)
change from baseline after 3 and 6 weeks
Vitamin D forms 1
Time Frame: change from baseline after 3 and 6 weeks
1,25(OH)2D2 (nmol/l)
change from baseline after 3 and 6 weeks
Vitamin D forms 2
Time Frame: change from baseline after 3 and 6 weeks
1,25(OH)2D3 (nmol/l)
change from baseline after 3 and 6 weeks
Vitamin D forms 3
Time Frame: change from baseline after 3 and 6 weeks
24,25(OH)2D (nmol/l)
change from baseline after 3 and 6 weeks
Vitamin D forms 4
Time Frame: change from baseline after 3 and 6 weeks
20(OH)D (nmol/l)
change from baseline after 3 and 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 5, 2018

Primary Completion (Actual)

April 30, 2018

Study Completion (Actual)

April 30, 2018

Study Registration Dates

First Submitted

March 29, 2018

First Submitted That Met QC Criteria

April 13, 2018

First Posted (Actual)

April 17, 2018

Study Record Updates

Last Update Posted (Estimate)

February 22, 2023

Last Update Submitted That Met QC Criteria

February 18, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • H5_18

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vitamin D3 Deficiency

Clinical Trials on Wheat germ oil (UV treated)

3
Subscribe